- Clinical Assistant Professor, Medicine - (Clinical Series Track)
- MBChB Medicine
- University of Baghdad, College of Medicine, Baghdad, Iraq
- MPH Applied Epidemiology
- University of Arizona, College of Public Health, Tucson, Arizona, United States
- University of Arizona, Tucson, Arizona (2018 - Ongoing)
- The 43rd Remington Winter Course in Infectious Diseases Scholarship Grant
- The 43rd Remington Winter Course, Winter 2017
- American Society of Transplantation Fellows Symposium Travel Grant Award
- American Society of Transplantation, Fall 2017
- IDWeek Trainee Travel Grant Award
- Infectious Diseases Society of America, Fall 2017
- American Society for Microbiology Microbe 2016: Travel Grant Award
- American Society for Microbiology, Summer 2016
Licensure & Certification
- Board Certified Internal Medicine, American Board of Internal Medicine (2015)
- Board Certified Infectious Diseases, American Board of Internal Medicine (2016)
- Medical License in Internal Medicine, Arizona Medical Board (2018)
Dr. Al-Obaidi’s research interest focuses on the infections in the immunocompromised population, especially within the solid organ and bone marrow transplantation populations. He is currently working on multiple projects studying invasive fungal infections and Cytomegalovirus infection in solid organ transplant patients. His work will help better understand the risk factors and methods to prevent infectious complications in transplant patients. Outside the field of transplant infectious diseases, Dr. Al-Obaidi is interested in studying fungal infections, including Candidiasis, invasive mold infection, and antifungal resistance. Dr. Al-Obaidi is also involved in multiple clinical trials studying investigational drugs against CMV and fungal infections.
No activities entered.
- Streling, A. P., Al Obaidi, M. M., Lainhart, W. D., Zangeneh, T., Khan, A., Dinh, A. Q., Hanson, B., Arias, C. A., & Miller, W. R. (2021). Evolution of Cefiderocol Non-Susceptibility in Pseudomonas aeruginosa in a Patient Without Previous Exposure to the Antibiotic. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.More infoWe report the emergence of non-susceptibility to cefiderocol from a subpopulation of Pseudomonas aeruginosa recovered from a patient without history of cefiderocol exposure. Whole genome sequencing identified mutations in major iron transport pathways previously associated with cefiderocol uptake. Susceptibility testing should be performed before therapy with siderophore cephalosporins.
- Adams, M., Bouzigard, R., Al-Obaidi, M., & Zangeneh, T. T. (2020). Perinephric abscess in a renal transplant recipient due to Mycoplasma hominis: Case report and review of the literature. Transplant infectious disease : an official journal of the Transplantation Society, 22(5), e13308.More infoA 42-year-old man presented with nausea, malaise, and pain at his renal graft site 4 months following deceased donor renal transplant. His transplantation had been complicated by urinary leak with delayed wound closure requiring ureteral revision with biologic mesh placement. The initial evaluation in the hospital revealed urinalysis with significant pyuria as well as abdominal CT imaging concerning for abscess formation anterior to the grafted kidney. Interventional radiology (IR) guided drainage of this abscess yielded growth of Enterococcus faecalis treated with intravenous ampicillin/sulbactam. He continued to have pain at his graft site and repeat imaging revealed a persistent abscess despite prolonged antimicrobial therapy. Urine cultures isolated Mycoplasma species. A repeat aspirate of abscess fluid collected and Mycoplasma hominis was identified by molecular test. Patient's symptoms abated and his abscess completely resolved on repeat imaging after completing a course of oral moxifloxacin and doxycycline. His immunosuppression did not require adjustment and the renal graft continued to function well following this therapy. Mycoplasma and Ureaplasma should be considered as a potential etiology for perinephric abscess in renal transplant recipients.
- Bardwell, J., Youseffi, B., Marquez, J., Zangeneh, T. T., & Al-Obaidi, M. (2020). Pulmonary Mucormycosis in a Heart Transplant Patient. The American journal of medicine, 133(9), e524-e525.
- Nix, D. E., Hayes, J. F., Al Obaidi, M., & Zangeneh, T. (2020). Fixed Dosing of Amphotericin B in Morbidly Obese Individuals. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
- Al-Obaidi, M., Hasbun, R., Vigil, K. J., Edwards, A. R., Chavez, V., Hall, D. R., Dar, W. A., De Golovine, A., Ostrosky-Zeichner, L., Bynon, J. S., & Nigo, M. (2019). Seroprevalence of Strongyloides stercoralis and Evaluation of Universal Screening in Kidney Transplant Candidates: A Single-Center Experience in Houston (2012-2017). Open forum infectious diseases, 6(7).More infoDisseminated strongyloidiasis in solid organ transplant recipients is a rare but devastating infection. In our center, we implemented a universal screening of all candidates for kidney transplantation. We assessed the seroprevalence and utility of universal screening for strongyloidiasis in our center.
- Al-Obaidi, M., Younes, P., & Ostrosky-Zeichner, L. (2018). Post-exposure prophylaxis with isavuconazole after occupational exposure to. Oxford medical case reports, 2018(10), omy062.More infoInvasive mucormycosis is typically seen in patients with hematological malignancies, diabetes and other conditions that affect the immune system. However, locally invasive disease can also be seen in both immunocompromised and immunocompetent hosts after trauma and direct inoculation. Since historically post-exposure prophylaxis with lipid-based amphotericin B compounds has not been feasible because of a high toxicity profile, there is no experience regarding the role of post-exposure prophylaxis after injuries contaminated with agents of mucormycosis. We describe the first case of a patient with occupational exposure to that received post-exposure prophylaxis with oral isavuconazole.
- Ostrosky-Zeichner, L., & Al-Obaidi, M. (2017). Invasive Fungal Infections in the Intensive Care Unit. Infectious disease clinics of North America, 31(3), 475-487.More infoPatients in the intensive care unit are exposed to multiple stressors that predispose them to invasive fungal infections (IFIs), which carry high morbidity and mortality. Getting acquainted with the diagnostic methods and therapies is imperative for patient safety and for providing high-quality health care. This article focuses on the most frequent IFIs: invasive candidiasis and invasive aspergillosis.
- Al-Obaidi, M. M., & Khasawneh, F. A. (2015). Progressive headache in a 48-year-old man. BMJ case reports, 2015.
- Khasawneh, F. A., & Al-Obaidi, M. M. (2015). New onset seizures and CNS tuberculoma. QJM : monthly journal of the Association of Physicians, 108(3), 261-2.
- Al-Obaidi, M., & Zangeneh, T. T. (2020, Fall). Characteristics of Candidemia in a Coccidioidomycosis Endemic Region. IDSA - ID Week 2020. Online only: Infectious Diseases Society of America.
- Al-Obaidi, M., Zangeneh, T. T., Bardwell, J., Youseffi, B., Bouzigard, R., & Le, C. (2020, Summer). A Comparative Analysis of Mucormycosis in Solid Organ Transplant Recipients and Other Immunosuppressed Hosts Including Patients with Uncontrolled Diabetes. ATC 2020 Virtual Congress. Online Only: American Transplant Congress.
- Al-Obaidi, M., Zangeneh, T. T., & Sumaya, F. (2019, June). The Natural History and Time to Seroconversion of CMV in the Era of Post-Transplantation Chemoprophylaxis. American Transplant Congress Annual Meeting. Boston, MA: American Transplant Congress.
- Al-Obaidi, M., Zangeneh, T. T., Adams, M., & Bouzigard, R. (2019, Oct). Peri-transplant Abscess Due to Mycoplasma hominis. American College of Physicians, Arizona Chapter, Annual Meeting. Tucson, AZ: American College of Physicians, Arizona Chapter.
- Al-Obaidi, M., Zangeneh, T. T., Bardwell, J. R., & Youssefi, B. (2019, Oct). Invasive Pulmonary Mucormycosis in a Heart Transplant Recipient. American College of Physicians, Arizona Chapter, Annual Meeting. Tucson: American College of Physicians, Arizona Chapter.
- Al-Obaidi, M., Zangeneh, T. T., Kaur, A., Bracamonte, E. R., & Youssefi, B. (2019, Oct). Pitfalls in the Diagnosis of Pneumocystis Pneumonia (PCP) by Staining Methods in Respiratory Specimens. American College of Physicians, Arizona Chapter, Annual Meeting. Tucson, AZ: American College of Physicians, Arizona Chapter.
- Al-Obaidi, M., Vigil, K. J., Hasbun, R., De Golovine, A., Machicao, V., Ostrosky, L. Z., Bynon, J. S., & Nigo, M. (2018, June). Strongyloides Pre-transplant Screening in Solid Organ Transplantation (SOT): Single Center Analysis. American Transplant Congress Annual Meeting. Seattle, WA: American Transplant Congress.
- Al-Obaidi, M., & Ostrosky, L. (2017, Jan). World-Wide Epidemiology of FKS Mutations: A systematic review of the literature. Antibiotic Resistance Symposium: Novel Frontiers in Antimicrobial Research. Houston, TX: Center for Antimicrobial Resistance and Microbial Genomics at McGovern Medical School, The University of Texas.
- Al-Obaidi, M., Vigil, K. J., & Barnett, B. (2017, Oct). Hepatitis C Viremia Post Direct Acting Theraphy Did Not Correlate with Treatment Failure in HCV/HIV Co-Infected Patients. IDWeek 2017. San Diego, CA: Infectious Diseases Society of America.
- Al-Obaidi, M., Vigil, K. J., Dang, B., & Barnett, B. (2017, Oct). Real World Experience of Sofosbuvir/Ledipasvir Therapy in HIV Patients Co-infected with HCV: A Retrospective Study. IDWeek 2017. San Diego, CA: Infectious Diseases Society of America.
- Al-Obaidi, M., Corsi, G., Wanger, A., & Ostrosky, L. (2016, Oct). Epidemiology and Natural History of Non-Tuberculous Mycobacterial Surgical Sites Infections. IDWeek. New Orleans, LA: Infectious Diseases Society of America.
- Al-Obaidi, M., Dirk, T., & Ostrosky, L. (2016, June). World-Wide Epidemiology of FKS Mutations: A systematic review of the literature. International Conference on Antimicrobial Agents and Chemotherapy. Boston, MA: American Society for Microbiology.
- Al-Obaidi, M., Echendu, C. E., & Ahmed, M. (2014, Feb). Marchiafava-Bignami Disease in a Patient with History of Alcohol and Cocaine Abuse. Society of General Internal Medicine Southern Regional Meeting. New Orleans, LA: Society of General Internal Medicine.